Holen Sie sich die Stockscreener-App
576.53
0.05%
-1.37
Schlusskurs vom Vortag:
$577.90
Offen:
$581.99
24-Stunden-Volumen:
325.30K
Relative Volume:
0.28
Marktkapitalisierung:
$60.11B
Einnahmen:
$14.21B
Nettoeinkommen (Verlust:
$4.46B
KGV:
14.53
EPS:
39.68
Netto-Cashflow:
$3.56B
1W Leistung:
-1.59%
1M Leistung:
+3.35%
6M Leistung:
-15.66%
1J Leistung:
-50.58%
1-Tages-Spanne:
$574.98
$588.70
1-Wochen-Bereich:
$570.35
$590.96
52-Wochen-Spanne:
$476.49
$1,182.31
Regeneron Pharmaceuticals Inc Stock (REGN) Company Profile
Firmenname
Regeneron Pharmaceuticals Inc
Sektor
Branche
Telefon
(914) 847-7000
Adresse
777 OLD SAW MILL RIVER ROAD, TARRYTOWN, NY
Vergleichen Sie REGN mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
REGN
Regeneron Pharmaceuticals Inc
|
577.02 | 61.55B | 14.21B | 4.46B | 3.56B | 39.68 |
|
VRTX
Vertex Pharmaceuticals Inc
|
395.68 | 100.25B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
449.54 | 58.53B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
712.76 | 43.59B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
337.71 | 33.67B | 3.81B | -644.79M | -669.77M | -6.24 |
Regeneron Pharmaceuticals Inc Stock (REGN) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-08-14 | Eingeleitet | Rothschild & Co Redburn | Buy |
| 2025-06-30 | Herabstufung | Argus | Buy → Hold |
| 2025-05-30 | Herabstufung | RBC Capital Mkts | Outperform → Sector Perform |
| 2025-05-30 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2025-05-14 | Hochstufung | Citigroup | Neutral → Buy |
| 2025-04-22 | Fortgesetzt | Cantor Fitzgerald | Overweight |
| 2025-02-05 | Hochstufung | Leerink Partners | Market Perform → Outperform |
| 2025-01-16 | Herabstufung | UBS | Buy → Neutral |
| 2024-12-10 | Fortgesetzt | BofA Securities | Underperform |
| 2024-11-15 | Eingeleitet | Wolfe Research | Outperform |
| 2024-11-14 | Eingeleitet | Citigroup | Neutral |
| 2024-09-24 | Herabstufung | Leerink Partners | Outperform → Market Perform |
| 2024-03-12 | Eingeleitet | Bernstein | Outperform |
| 2024-01-12 | Hochstufung | RBC Capital Mkts | Sector Perform → Outperform |
| 2023-11-09 | Eingeleitet | Deutsche Bank | Hold |
| 2023-11-03 | Hochstufung | Raymond James | Mkt Perform → Outperform |
| 2023-08-21 | Hochstufung | Canaccord Genuity | Hold → Buy |
| 2023-08-21 | Bestätigt | Oppenheimer | Perform |
| 2023-06-28 | Herabstufung | Canaccord Genuity | Buy → Hold |
| 2023-03-27 | Hochstufung | SVB Securities | Market Perform → Outperform |
| 2023-03-24 | Hochstufung | Jefferies | Hold → Buy |
| 2023-03-23 | Hochstufung | Raymond James | Underperform → Mkt Perform |
| 2023-01-30 | Hochstufung | Cowen | Market Perform → Outperform |
| 2023-01-20 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2022-10-26 | Herabstufung | Raymond James | Mkt Perform → Underperform |
| 2022-10-17 | Herabstufung | Evercore ISI | Outperform → In-line |
| 2022-09-09 | Hochstufung | Jefferies | Underperform → Hold |
| 2022-09-09 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2022-07-25 | Herabstufung | SVB Leerink | Outperform → Mkt Perform |
| 2022-07-13 | Eingeleitet | Cantor Fitzgerald | Neutral |
| 2022-06-06 | Eingeleitet | Jefferies | Underperform |
| 2022-05-23 | Eingeleitet | SVB Leerink | Outperform |
| 2022-01-05 | Herabstufung | BofA Securities | Neutral → Underperform |
| 2022-01-03 | Hochstufung | Bernstein | Mkt Perform → Outperform |
| 2021-12-15 | Herabstufung | Bernstein | Outperform → Mkt Perform |
| 2021-12-09 | Fortgesetzt | Wells Fargo | Overweight |
| 2021-12-07 | Fortgesetzt | Cowen | Market Perform |
| 2021-12-06 | Eingeleitet | Goldman | Buy |
| 2021-11-19 | Fortgesetzt | BMO Capital Markets | Outperform |
| 2021-11-05 | Herabstufung | The Benchmark Company | Buy → Hold |
| 2021-06-29 | Eingeleitet | H.C. Wainwright | Buy |
| 2021-01-25 | Hochstufung | BMO Capital Markets | Market Perform → Outperform |
| 2021-01-13 | Hochstufung | The Benchmark Company | Hold → Buy |
| 2021-01-08 | Hochstufung | Citigroup | Neutral → Buy |
| 2020-10-05 | Hochstufung | Cantor Fitzgerald | Neutral → Overweight |
| 2020-08-20 | Herabstufung | The Benchmark Company | Buy → Hold |
| 2020-07-09 | Hochstufung | SunTrust | Hold → Buy |
| 2020-05-26 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2020-04-28 | Herabstufung | Citigroup | Buy → Neutral |
| 2020-04-17 | Hochstufung | The Benchmark Company | Hold → Buy |
| 2020-04-08 | Eingeleitet | The Benchmark Company | Hold |
| 2020-03-31 | Eingeleitet | Wolfe Research | Peer Perform |
| 2020-02-27 | Eingeleitet | Barclays | Overweight |
| 2020-02-26 | Hochstufung | Canaccord Genuity | Hold → Buy |
| 2020-02-26 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2020-02-25 | Hochstufung | Jefferies | Hold → Buy |
| 2020-02-11 | Hochstufung | Argus | Hold → Buy |
| 2019-12-24 | Eingeleitet | Raymond James | Mkt Perform |
| 2019-12-16 | Herabstufung | Evercore ISI | Outperform → In-line |
| 2019-12-13 | Hochstufung | Credit Suisse | Neutral → Outperform |
| 2019-11-12 | Eingeleitet | SunTrust | Hold |
| 2019-11-07 | Hochstufung | Citigroup | Neutral → Buy |
| 2019-10-17 | Fortgesetzt | BofA/Merrill | Neutral |
| 2019-09-23 | Hochstufung | Guggenheim | Neutral → Buy |
Alle ansehen
Regeneron Pharmaceuticals Inc Aktie (REGN) Neueste Nachrichten
Regeneron Pharmaceuticals, Inc. $REGN Shares Purchased by GW Henssler & Associates Ltd. - MarketBeat
Key resistance and support levels for Regeneron Pharmaceuticals Inc.Portfolio Return Report & Free Accurate Trade Setup Notifications - Newser
What candlestick patterns are forming on Regeneron Pharmaceuticals Inc.Market Risk Analysis & Growth Focused Entry Reports - Newser
Will Regeneron Pharmaceuticals Inc. outperform the marketOptions Play & Low Volatility Stock Recommendations - Newser
How Is Regeneron’s Stock Performance Compared to Other Pharma Stocks? - MSN
How to track smart money flows in Regeneron Pharmaceuticals Inc.2025 AllTime Highs & Safe Capital Growth Trade Ideas - Newser
How Is Regeneron’s Stock Performance Compared To Other Pharma Stocks? - Barchart.com
The Manufacturers Life Insurance Company Increases Stock Holdings in Regeneron Pharmaceuticals, Inc. $REGN - MarketBeat
Regeneron Pharmaceuticals Inc. stock trend forecastJuly 2025 Movers & High Conviction Trade Alerts - Newser
Real time social sentiment graph for Regeneron Pharmaceuticals Inc. - Newser
OMERS ADMINISTRATION Corp Sells 639 Shares of Regeneron Pharmaceuticals, Inc. $REGN - MarketBeat
Landscape Capital Management L.L.C. Takes $1.03 Million Position in Regeneron Pharmaceuticals, Inc. $REGN - MarketBeat
What are Regeneron Pharmaceuticals Inc.’s recent SEC filings showingJuly 2025 Pullbacks & Fast Gain Swing Trade Alerts - khodrobank.com
Intraday pattern recognizer results for Regeneron Pharmaceuticals Inc.July 2025 Catalysts & Safe Investment Capital Preservation Plans - Newser
Regeneron: Drug Pricing Woes Notwithstanding, Due For A Major Comeback (NASDAQ:REGN) - Seeking Alpha
Can Regeneron Pharmaceuticals Inc. expand its profit marginsWeekly Investment Recap & Accurate Entry/Exit Alerts - خودرو بانک
Wellington Management Group LLP Cuts Stake in Regeneron Pharmaceuticals, Inc. $REGN - MarketBeat
Kestra Advisory Services LLC Reduces Holdings in Regeneron Pharmaceuticals, Inc. $REGN - MarketBeat
Lansforsakringar Fondforvaltning AB publ Reduces Stock Position in Regeneron Pharmaceuticals, Inc. $REGN - MarketBeat
Evercore ISI Maintains a Buy on Regeneron Pharmaceuticals (REGN) With a $750 PT - MSN
Tema Etfs LLC Has $2.73 Million Holdings in Regeneron Pharmaceuticals, Inc. $REGN - MarketBeat
COPD Market Positioned for Accelerated Development Through 2034, DelveInsight Finds | Genentech, GlaxoSmithKline, Verona Pharma, Regeneron Pharma, Sanofi, MedImmune, EpiEndo Pharma, Tetherex Pharma - Barchart.com
Regeneron Pharmaceuticals, Inc. $REGN is Armistice Capital LLC's 10th Largest Position - MarketBeat
What the charts say about Regeneron Pharmaceuticals Inc. todayStock Surge & Long-Term Safe Investment Plans - Newser
What makes Regeneron Pharmaceuticals Inc. stock price move sharplyPortfolio Value Report & Free Weekly Watchlist of Top Performers - Newser
Orion Investment Co Boosts Position in Regeneron Pharmaceuticals, Inc. $REGN - MarketBeat
Guggenheim Capital LLC Sells 4,547 Shares of Regeneron Pharmaceuticals, Inc. $REGN - MarketBeat
Regeneron Pharmaceuticals (NASDAQ:REGN) Price Target Raised to $781.00 - MarketBeat
Real time alert setup for Regeneron Pharmaceuticals Inc. performanceWeekly Loss Report & Reliable Entry Point Trade Alerts - Newser
What is Regeneron Pharmaceuticals Inc. s 5 year growth outlookWeekly Investment Recap & Expert Approved Trade Ideas - khodrobank.com
Regeneron Pharmaceuticals, Inc. $REGN Holdings Increased by Comerica Bank - MarketBeat
Analyzing Regeneron Pharmaceuticals Inc. with multi timeframe charts2025 Top Decliners & Expert Approved Trade Ideas - Newser
Will Regeneron Pharmaceuticals Inc. stock recover after earnings2025 Key Highlights & Expert Verified Movement Alerts - خودرو بانک
Canada Pension Plan Investment Board Decreases Position in Regeneron Pharmaceuticals, Inc. $REGN - MarketBeat
Ieq Capital LLC Acquires 4,381 Shares of Regeneron Pharmaceuticals, Inc. $REGN - MarketBeat
Tools to assess Regeneron Pharmaceuticals Inc.’s risk profileLayoff News & Free Weekly Chart Analysis and Trade Guides - Newser
How to contact the Daily Bulletin - FinancialContent
Key resistance and support levels for Regeneron Pharmaceuticals IncJuly 2025 Spike Watch & Reliable Price Breakout Alerts - Newser
Harvest Portfolios Group Inc. Acquires 11,555 Shares of Regeneron Pharmaceuticals, Inc. $REGN - MarketBeat
CW Advisors LLC Purchases Shares of 1,428 Regeneron Pharmaceuticals, Inc. $REGN - MarketBeat
Kayne Anderson Rudnick Investment Management LLC Buys 3,288 Shares of Regeneron Pharmaceuticals, Inc. $REGN - MarketBeat
Regeneron Pharmaceuticals Inc. stock trend outlook and recovery pathWeekly Profit Analysis & Breakout Confirmation Alerts - Newser
Rafferty Asset Management LLC Trims Stock Holdings in Regeneron Pharmaceuticals, Inc. $REGN - MarketBeat
1832 Asset Management L.P. Has $1.33 Million Stock Holdings in Regeneron Pharmaceuticals, Inc. $REGN - MarketBeat
Regeneron Pharmaceuticals Inc. stock prediction for this weekQuarterly Growth Report & AI Driven Stock Reports - Newser
Ceredex Value Advisors LLC Buys New Shares in Regeneron Pharmaceuticals, Inc. $REGN - MarketBeat
Regeneron Pharmaceuticals, Inc. $REGN Shares Sold by Corebridge Financial Inc. - MarketBeat
FORA Capital LLC Has $3.46 Million Stake in Regeneron Pharmaceuticals, Inc. $REGN - MarketBeat
What to expect from Regeneron Pharmaceuticals Inc. in the next 30 days2025 Performance Recap & Entry Point Strategy Guides - Newser
Finanzdaten der Regeneron Pharmaceuticals Inc-Aktie (REGN)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.87%
0.83%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):